Global Cord Blood Corporation Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2020
3Q20 Added 23,387 New Subscribers Revenues Up 31.7% YoY to RMB334.7 Million ($48.1 Million) Operating Income Up 65.1% YoY to RMB152.9 Million ($22.0 Million) Non-GAAP Operating Income Up 56.7% YoY to RMB165.0 Million ($23.7 Million) Conference Call to be Held on March 12, 2020, at 8:00 a.m. ET ...
Global Cord Blood Corporation to Report Third Quarter and First Nine Months Fiscal 2020 Financial Results
HONG KONG, March 9, 2020 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) (the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today announced that it plans to release unaudited financial ...
Global Cord Blood Corporation Provides Update on Impact of Coronavirus
HONG KONG, Feb. 14, 2020 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) ("GCBC" or the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today provided an update on the impact of the 2019 ...
Global Cord Blood Corporation Appoints Mr. Siu Chuen Cheng as Independent Non-executive Director
HONG KONG, Feb. 6, 2020 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) ("GCBC" or the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today announced the appointment of Mr.Siu Chuen Chen...
Global Cord Blood Corporation Appoints Mr. Siu Chuen Cheng as Independent Non-executive Director
HONG KONG, Feb. 6, 2020 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) ("GCBC" or the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today announced the appointment of Mr.Siu Chuen Chen...
PRC NHC Issues New Policy on Cord Blood Banks, Implementation Rules To Be Provided
HONG KONG, Dec. 6, 2019 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) (the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today reported thatChina's National Health Commission ("NHC") ...
Global Cord Blood Corporation Announces Results of 2019 Annual General Meeting
HONG KONG, Dec. 5, 2019 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) ("GCBC" or the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services, today announced the results of its 2019 Annual Gene...
Global Cord Blood Corporation Reports Financial Results for the Second Quarter and First Half of Fiscal 2020
HONG KONG, Nov. 27, 2019 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) ("GCBC" or the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today announced its unaudited financial results for...
Global Cord Blood Corporation to Report Second Quarter and First Half Fiscal 2020 Financial Results
HONG KONG, Nov. 21, 2019 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) (the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today announced that it plans to release unaudited financia...
Global Cord Blood Corp Comments on New Regulation
HONG KONG, Nov. 20, 2019 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) (the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today commented on a new regulation related to companies in ...
Global Cord Blood Corporation Appoints Mr. Jack Chow As an Independent Non-executive Director
HONG KONG, Nov. 11, 2019 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) ("GCBC" or the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today announced the appointment of a new independen...
Global Cord Blood Corporation to Hold Annual General Meeting in Hong Kong on December 5, 2019
HONG KONG, Sept. 20, 2019 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) ("GCBC" or the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services, today announced that the Company will hold its 20...
Global Cord Blood Corporation Reports Financial Results for the First Quarter of Fiscal 2020
1Q20 Added 20,815 New Subscribers Revenues Up 16.9% YoY to RMB273.4 Million ($39.8 Million ) Gross Profit Up 19.4% YoY to RMB227.6 million ($33.2 million) Operating Income Up 17.8% YoY to RMB112.4 Million ($16.4 Million) Non-GAAP Operating Income Up 15.0% YoY to RMB...
Global Cord Blood Corporation Reports Financial Results for the First Quarter of Fiscal 2020
1Q20 Added 20,815 New Subscribers Revenues Up 16.9% YoY to RMB273.4 Million ($39.8 Million ) Gross Profit Up 19.4% YoY to RMB227.6 million ($33.2 million) Operating Income Up 17.8% YoY to RMB112.4 Million ($16.4 Million) Non-GAAP Operating Income Up 15.0% YoY to RMB...
Global Cord Blood Corporation to Report First Quarter Fiscal 2020 Financial Results
HONG KONG, Aug. 21, 2019 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) (the "Company") today announced that it plans to release financial results for the first quarter fiscal 2020 onTuesday, August 27, 2019, after the market close. The Company will host a conference call at 8:00 a.m....
Global Cord Blood Corporation Files Its Annual Report on Form 20-F
HONG KONG, July 24, 2019 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) ("GCBC" or the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services, today announced that the Company filed its Annual ...
Global Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2019
Added 22,194 New Subscribers in 4Q19 4Q19 Revenues Increased by 8.0% YoY to RMB251.7 Million ($37.5 Million) 4Q19 Operating Income Increased to RMB88.9 Million ($13.2 Million) Conference Call to be Held on June 19, 2019 at 8:00 a.m. ET HONG KONG, June 19, 2019 /PRNewswire/ -- Global Cord Blood Corp...
Global Cord Blood Corporation to Report Fourth Quarter and Full Year Fiscal 2019 Financial Results
HONG KONG, June 11, 2019 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) (the "Company") today announced that it plans to release financial results for the fourth quarter and full year fiscal 2019 onTuesday, June 18, 2019, after the market close. The Company will host a conference call...
Global Cord Blood Corporation Announces Formation of a Special Committee to Evaluate Non-Binding Proposal
HONG KONG, June 6, 2019 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) (the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today announced that in response to the non-binding proposal l...
Global Cord Blood Corporation Announces Formation of a Special Committee to Evaluate Non-Binding Proposal
HONG KONG, June 6, 2019 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) (the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today announced that in response to the non-binding proposal l...
